Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
about
Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research AgendaEvaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.Why being an expert - despite xpert -remains crucial for children in high TB burden settings.Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in CambodiaManagement of drug resistantTB in patients with HIV co-infection.Rolling Out Xpert® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems StrengtheningDiagnosis of opportunistic infections: HIV co-infections - tuberculosis.Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
P2860
Q26767271-1D5A089E-3F98-4C48-92A1-2EAA2357DD55Q28552438-8C644E46-59A6-47E5-B834-F6DD3E3E832CQ33742861-C26E1173-CC84-4DA1-B08E-5D55428BF1F7Q35941022-E742899C-0ABD-4743-BB0E-81449A0C2718Q36136013-2147BBB7-B829-44B6-8FFF-FF738AB6077CQ36159840-D6675F63-7AB4-4395-91EE-B0FE674CF0D1Q36174697-B7C3E0BA-79CE-4BDA-8B8F-01CC459261F1Q36271967-C0B7BC98-123C-408E-B1AF-814CA644300AQ36617071-79397420-B9DA-43FA-A962-7CE8F9D4533CQ37020517-08AD394F-9AC2-4AEE-94AB-2BBE3DFBCF0EQ38610637-C779F4C4-2515-4B63-BFA0-8E421ED4424EQ38645708-8738B452-B1DC-4ABC-AB0A-351B71E8EB5AQ39070206-C6525CB3-BB41-49EB-AA3C-59B82ADBCC64Q47547617-4EF1954F-7737-42B5-A91B-E075805C79FE
P2860
Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@ast
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@en
type
label
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@ast
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@en
prefLabel
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@ast
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@en
P2093
P2860
P50
P356
P1476
Impact of Xpert MTB/RIF on Ant ...... ic Randomized Controlled Trial
@en
P2093
B Makamure
J Z Metcalfe
S Zinyowera
P2860
P304
P356
10.1093/OFID/OFU038
P577
2014-03-01T00:00:00Z